missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Fluorescein-CREBtide Substrate
Fluorescein-CREBtide Substrate
Brand: Invitrogen PV3508
This item is not returnable.
View return policy
Description
A fluorescein-labeled peptide substrate that is based upon the CREB ( cAMP responsive element binding) protein. The peptide substrate is phosphorylated by a wide range of Ser/Thr kinases.For use in combination with the LanthaScreen™ Tb-CREB [pSer133] antibody (PV3542) to evaluate inhibitors in medium to high throughput screening applications.

Spécification
Fluorescein- KRREILSRRPSYR | |
1 mg/mL Fluorescein-CREBtide substrate in water. Store at -20°C and protect from light. | |
1 mg | |
Peptide-Based Substrate | |
Serine/Threonine Kinases | |
2076 Da | |
AMPK (A2/B1/G1), STK22D, CAMK2B, CHEK1, MAPKAPK2, PASK, PIM2, PRKCN, PRKD2, PRKG2, RPS6KA5, AMPK (A1/B1/G1), AURKA, CAMK1D, CAMK4, CHEK2, MAPKAPK3, PIM1, PKN1, PRKD1, PRKG1, RPS6KA4, CAMK1 |
Biochemical terbium phospho-specific activity | |
Fluorescence | |
Fluorescein-CREBtide | |
Kinase Substrate | |
FITC (Fluorescein) | |
Dry Ice | |
AMPK, AURKA, CAMK1, CAMKID, CAMK2A, CAMK2B, CAMK4, CHEK1, CHEK2, MAPKAPK2, MAPKAPK3, PASK, PIM1, PIM2, PKN1, PRKACA, PRKD1, PRKD2, PRKG1, PRKG2, RPS6KA4, RPS6KA5, STK22D |
Certificates
A lot number is required to show results for certificates. To find your lot number on previous orders use our order status area.
5 results found
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
1786384F | Certificate of Analysis | 21/02/2025 | PV3508 |
1786384E | Certificate of Analysis | 06/02/2023 | PV3508 |
1786384D | Certificate of Analysis | 13/06/2022 | PV3508 |
1786384C | Certificate of Analysis | 03/02/2021 | PV3508 |
1786384B | Certificate of Analysis | 07/04/2020 | PV3508 |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Fluorescein-CREBtide Substrate > 1mg
For Research Use Only. Not for use in diagnostic procedures.
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu